ATHENA NEUROSCIENCES FILES IND FOR TIZANIDINE PHASE III TRIAL, EXTENDS LILLY ALZHEIMER's RESEARCH PACT ON EVE OF $ 35 MIL. INITIAL PUBLIC OFFERING

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".